Walgreens and Verily announce partnerships for diabetes, medication adherence

Walgreens Boots Alliance and Verily, Alphabet Inc.’s life sciences research arm, announced multiple plans on Wednesday to help patients with chronic conditions. One project uses “devices and other approaches” to improve medication adherence, and the other “provides tools, coaching and remote access to specialty doctors to help people with diabetes to manage their condition anytime, anywhere,” according to a press release. The diabetes solution, Onduo, will target Walgreens employees and family members through the company’s employee health plan.